Dorsal column nuclei

From WikiMD's WELLNESSPEDIA

(Redirected from Cuneate nucleus)

Dorsal column nuclei are a pair of nuclei in the dorsal columns of the medulla oblongata. They are also known as the gracile nucleus and cuneate nucleus. These nuclei are part of the somatosensory system and are involved in the sensation of fine touch and proprioception (body position).

Anatomy[edit]

The dorsal column nuclei are located in the medulla oblongata, the lower half of the brainstem. They consist of two pairs of nuclei: the gracile nucleus and the cuneate nucleus. The gracile nucleus is located medially and receives sensory input from the lower body and legs, while the cuneate nucleus is located laterally and receives sensory input from the upper body and arms.

Function[edit]

The dorsal column nuclei are part of the dorsal column-medial lemniscus pathway, a sensory pathway of the central nervous system. This pathway is responsible for transmitting information about fine touch, vibration, and proprioception from the body to the brain. The information is sent from the receptors in the skin and muscles to the dorsal column nuclei, where it is processed and sent to the thalamus and then to the cortex.

Clinical significance[edit]

Damage to the dorsal column nuclei can result in a loss of fine touch and proprioception. This can be caused by a variety of conditions, including stroke, multiple sclerosis, and neurodegenerative diseases. Treatment typically involves managing the underlying condition and may include physical therapy to help improve proprioception.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.